Modeling economic evaluations of pharmaceuticals: manipulation or valuable tool?
- 1 May 1999
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (5) , 896-908
- https://doi.org/10.1016/s0149-2918(99)80011-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Health and Economic Outcomes Modeling Practices: A Suggested FrameworkValue in Health, 1998
- A comparison of economic modelling and clinical trials in the economic evaluation of cholesterol-modifying pharmacotherapyHealth Economics, 1997
- Modelling in Ecomomic Evaluation: An Unavoidable Fact of LifeHealth Economics, 1997
- The future of pharmacoeconomics: bridging science and practiceClinical Therapeutics, 1996
- Guidelines for authors and peer reviewers of economic submissions to the BMJBMJ, 1996
- Cost-effectiveness of cholesterol lowering: Results from the Scandinavian Simvastatin Survival Study (4S)European Heart Journal, 1996
- Validating Literature-based Models with Direct Clinical Trial ResultsMedical Decision Making, 1996
- Problems of using modelling in the economic evaluation of health careHealth Economics, 1996
- The Journal's Policy on Cost-Effectiveness AnalysesNew England Journal of Medicine, 1994
- Issues in the Cross-National Assessment of Health TechnologyInternational Journal of Technology Assessment in Health Care, 1992